HonorHealth: procedure is cutting-edge congenital heart disease treatment
Staff Reports | Science & Technology
HonorHealth is offering the Medtronic Harmony Transcatheter Pulmonary Valve Therapy, which officials tell the Digital Free Press is improving care for adult patients living with congenital heart disease.
The new, minimally invasive treatment helps adult patients with damaged or malfunctioning pulmonary valves, often caused by this disease, to breathe easier and lead healthier, more active lives, according to a press release.
“We’re excited to be at the forefront of this groundbreaking treatment,” said Dr. Haidar Yassin, interventional cardiologist with HonorHealth Heart Care. “For many adults with congenital heart disease, this safe, less invasive option to traditional open-heart surgery gives patients a new lease on life, with faster recovery times and a much lower risk of complications.”
Dr. Yassin and Dr. Robert Riley, network director, cardiothoracic surgery with HonorHealth Heart Care, were part of the multi-disciplinary team that completed the first procedure at HonorHealth Scottsdale Shea Medical Center in December 2024.
“Advancements in medical research and treatment techniques are providing new hope for adults living with congenital heart disease, enabling us to offer more personalized care, better outcomes and an improved quality of life,’ says Dr. Tabitha Moe, program director, HonorHealth Adult Congenital Heart Disease program. “By focusing on early detection, innovative therapies and ongoing support, we can significantly enhance the long-term health of this growing population.”
